Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer

Ali Raza Khaki, Yong Shan, Richard E. Nelson, Sapna Kaul, John L. Gore, Petros Grivas, Stephen B. Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences